合理用药
不良反应
新药前沿
药物治疗
关键字:
搜索栏目:
 首页 >> 合理用药 >> 新药前沿
拜耳的Alpharadin成为前列腺癌治疗的突破进展
作者:网络来源 时间:2011-10-09 点击:401 来源:网络来源
<FONT size=3><FONT color=#333333>&nbsp;&nbsp;<SPAN style="FONT-SIZE: 12pt; COLOR: #333333; FONT-FAMILY: 宋体; mso-ascii-font-family: Arial; mso-bidi-font-family: Arial; mso-hansi-font-family: Arial; mso-font-kerning: 0pt; mso-ansi-language: De">据</SPAN><SPAN style="FONT-SIZE: 12pt; COLOR: #333333; FONT-FAMILY: 宋体; mso-ascii-font-family: Arial; mso-bidi-font-family: Arial; mso-hansi-font-family: Arial; mso-font-kerning: 0pt">华尔街日报</SPAN> <SPAN lang=EN-US style="FONT-SIZE: 12pt; COLOR: #333333; FONT-FAMILY: Arial; mso-font-kerning: 0pt" XML:LANG="EN-US">9</SPAN><SPAN style="FONT-SIZE: 12pt; COLOR: #333333; FONT-FAMILY: 宋体; mso-ascii-font-family: Arial; mso-bidi-font-family: Arial; mso-hansi-font-family: Arial; mso-font-kerning: 0pt">月</SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt; COLOR: #333333; FONT-FAMILY: Arial; mso-font-kerning: 0pt" XML:LANG="EN-US">26</SPAN><SPAN style="FONT-SIZE: 12pt; COLOR: #333333; FONT-FAMILY: 宋体; mso-ascii-font-family: Arial; mso-bidi-font-family: Arial; mso-hansi-font-family: Arial; mso-font-kerning: 0pt">日</SPAN><SPAN style="FONT-SIZE: 12pt; COLOR: #333333; FONT-FAMILY: 宋体; mso-ascii-font-family: Arial; mso-bidi-font-family: Arial; mso-hansi-font-family: Arial; mso-font-kerning: 0pt">报道:</SPAN>德国拜耳公司和挪威<SPAN lang=EN-US style="FONT-SIZE: 12pt; COLOR: #333333; FONT-FAMILY: Arial; mso-font-kerning: 0pt" XML:LANG="EN-US"><SPAN lang=EN-US style="FONT-SIZE: 12pt; COLOR: #333333; FONT-FAMILY: Arial; mso-font-kerning: 0pt" XML:LANG="EN-US">Algeta</SPAN></SPAN></FONT><SPAN style="FONT-SIZE: 12pt; COLOR: #333333; FONT-FAMILY: 宋体; mso-ascii-font-family: Arial; mso-bidi-font-family: Arial; mso-hansi-font-family: Arial; mso-font-kerning: 0pt">生物技术公司的实验性药物能够以小剂量放射线轰击入侵至骨组织的肿瘤,延长晚期前列腺癌患者生命。这在一项后期研究得到证实。</SPAN></FONT><SPAN lang=EN-US style="FONT-SIZE: 12pt; COLOR: #333333; FONT-FAMILY: Arial; mso-font-kerning: 0pt" XML:LANG="EN-US"><BR><SPAN style="mso-spacerun: yes"><FONT face=Arial><FONT size=3><FONT color=#333333>&nbsp;<WBR>&nbsp;<WBR>&nbsp;<WBR></FONT></FONT></FONT></SPAN></SPAN> <SPAN style="FONT-SIZE: 12pt; COLOR: #333333; FONT-FAMILY: 宋体; mso-ascii-font-family: Arial; mso-bidi-font-family: Arial; mso-hansi-font-family: Arial; mso-font-kerning: 0pt">拜耳</SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt; COLOR: #333333; FONT-FAMILY: Arial; mso-font-kerning: 0pt" XML:LANG="EN-US">/ Algeta</SPAN> <SPAN style="FONT-SIZE: 12pt; COLOR: #333333; FONT-FAMILY: 宋体; mso-ascii-font-family: Arial; mso-bidi-font-family: Arial; mso-hansi-font-family: Arial; mso-font-kerning: 0pt">的药物名为</SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt; COLOR: #333333; FONT-FAMILY: Arial; mso-font-kerning: 0pt" XML:LANG="EN-US">Alpharadin</SPAN><SPAN style="FONT-SIZE: 12pt; COLOR: #333333; FONT-FAMILY: 宋体; mso-ascii-font-family: Arial; mso-bidi-font-family: Arial; mso-hansi-font-family: Arial; mso-font-kerning: 0pt">,它被出席最近在瑞典召开的欧洲癌症研究会专家誉为前列腺癌治疗的一个重大进展,因为它是首个能够改善骨症状和延长生存期药物。</SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt; COLOR: #333333; FONT-FAMILY: Arial; mso-font-kerning: 0pt" XML:LANG="EN-US"><BR><SPAN style="mso-spacerun: yes"><FONT face=Arial><FONT size=3><FONT color=#333333>&nbsp;<WBR>&nbsp;<WBR>&nbsp;<WBR></FONT></FONT></FONT></SPAN></SPAN> <SPAN style="FONT-SIZE: 12pt; COLOR: #333333; FONT-FAMILY: 宋体; mso-ascii-font-family: Arial; mso-bidi-font-family: Arial; mso-hansi-font-family: Arial; mso-font-kerning: 0pt">拜耳计划在</SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt; COLOR: #333333; FONT-FAMILY: Arial; mso-font-kerning: 0pt" XML:LANG="EN-US">2012</SPAN><SPAN style="FONT-SIZE: 12pt; COLOR: #333333; FONT-FAMILY: 宋体; mso-ascii-font-family: Arial; mso-bidi-font-family: Arial; mso-hansi-font-family: Arial; mso-font-kerning: 0pt">年年中寻求美国获得美国</SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt; COLOR: #333333; FONT-FAMILY: Arial; mso-font-kerning: 0pt" XML:LANG="EN-US">FDA</SPAN><SPAN style="FONT-SIZE: 12pt; COLOR: #333333; FONT-FAMILY: 宋体; mso-ascii-font-family: Arial; mso-bidi-font-family: Arial; mso-hansi-font-family: Arial; mso-font-kerning: 0pt">批准。</SPAN>
返回>>>
浙江省医院药事管理质控中心网 版权所有@2008 All Right Reserved。 浙江省医院药事管理质控中心主办
地址:杭州市庆春路79号(310003)        Email:zhejiangyszk@163.com
建议浏览器IE6.0+ 分辨率:1024*768以上